Advanced Biomedical Research

Clinical symptoms of COVID-19 and their association with disease outcome

Document Type : Original Article

Authors

1 Department of Community and Family Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Vice Chancellery for Health, Isfahan University of Medical Sciences, Isfahan, Iran

3 Vice Chancellery for Health, Isfahan University of Medical Sciences; Social Determinants of Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: COVID-19 pandemic placed immense pressure on health systems. The current study aimed to evaluate the symptoms of COVID-19 in Isfahan province and their association with disease outcome. Materials and Methods: In this cross-sectional study, which was conducted on patients with a definite diagnosis of COVID-19, as a part of the investigations performed by the Deputy for Public Health of the Isfahan University of Medical Sciences, the frequency of underlying diseases, and general, respiratory, gastrointestinal, neurological, renal, cardiac, dermal, hearing symptoms are assessed using a checklist. The participants were followed up 1 month after definitive diagnosis, and the outcome of the disease (recovery or death) was recorded. Results: Of 300 patients, 143 (47.4%) were male and 157 (52.6%) were female. The mean age of patients was 43 ± 17.84 years. Muscle pain and fatigue were the most common early symptoms (63% and 60.3%, respectively). Age, sex, level of education, and occupation of patients and general, respiratory, and gastrointestinal symptoms and underlying diseases of respiratory disease showed a statistically significant association with the disease outcome (P < 0.05). Conclusion: General, respiratory, and gastrointestinal symptoms were associated with an increased risk of death due to COVID-19. General, visual, and hearing symptoms, and diabetes, cardiovascular diseases, and respiratory disease had a statistically significant association with the hospitalization of patients.

Keywords

1.
Kazeminia M, Jalali R, Vaisi-Raygani A, Khaledi-Paveh B, Salari N, Mohammadi M, et al. Fever and cough are two important factors in identifying patients with the COVID-19: A meta-analysis. J Mil Med 2020;22:193-202.  Back to cited text no. 1
    
2.
Galougahi MK, Ghorbani J, Bakhshayeshkaram M, Naeini AS, Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: The first report. Acad Radiol 2020;27:892-3.  Back to cited text no. 2
    
3.
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20:425-34.  Back to cited text no. 3
    
4.
Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect 2020;80:401-6.  Back to cited text no. 4
    
5.
Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020;295:210-7.  Back to cited text no. 5
    
6.
Beeching N, Fletcher T, Fowler R. Coronoavirus disease 2019 (COVID-19). BMJ Best Practices 2020. Accessed on: 25 March 2020.  Back to cited text no. 6
    
7.
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. European Archives of Oto-Rhino-Laryngology. 2020;277:2251-61.  Back to cited text no. 7
    
8.
Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020;35:1545-9.  Back to cited text no. 8
    
9.
Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): A clinical update. Front Med 2020;14:126-35.  Back to cited text no. 9
    
10.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.  Back to cited text no. 10
    
11.
Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol 2020;127:104378.  Back to cited text no. 11
    
12.
Bagheri SH, Asghari A, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran 2020;34:62.  Back to cited text no. 12
    
13.
Fricke-Galindo I, Falfán-Valencia R. Genetics insight for COVID-19 susceptibility and severity: A review. Front Immunol 2021;12:622176.  Back to cited text no. 13
    
14.
Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol 2020;92:2067-73.  Back to cited text no. 14
    
15.
Soares RC, Mattos LR, Raposo LM. Risk factors for hospitalization and mortality due to COVID-19 in Espírito Santo State, Brazil. Am J Trop Med Hyg 2020;103:1184-90.  Back to cited text no. 15
    
16.
Masetti C, Generali E, Colapietro F, Voza A, Cecconi M, Messina A, et al. High mortality in COVID-19 patients with mild respiratory disease. Eur J Clin Invest 2020;50:e13314.  Back to cited text no. 16
    
17.
Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020;14:395-403.  Back to cited text no. 17
    
18.
Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol 2020;92:1915-21.  Back to cited text no. 18
    
19.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nature Med 2020;26:1218-23.  Back to cited text no. 19
    
Advanced Biomedical Research
Volume 2022, January
January 2022
Pages 1-7